Nephrology Doctors in Morgantown, WV Accepting Medicare

8 Nephrology doctors found. Showing 1 - 8

Anthony J Parravani, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-598-4800    Fax: 304-293-6963

Dr. Bethany S Pellegrino, M. D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800    Fax: 304-598-4781

Dr. Mark Alan Poling, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-598-4850

Dr. Alvin H Moss, M. D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 600 Suncrest Town Centre Dr, Morgantown, WV 26505 Phone: 304-598-3484

Dr. Adeem Akbar, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-2551

Dinesh Kumar Kanagasabapathy Kannabhiran, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000

Dr. Karen Mackay, M. D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800    Fax: 304-293-6963

Dr. Rebecca J Schmidt, D. O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800    Fax: 304-293-6963

News Archive

Medicare advisory panel urges co-pay for home health visits

The Medicare Payment Advisory Panel recommended this policy as a means to discourage overuse of home health services, which are estimated to cost taxpayers nearly $20 billion a year and are also a source of health care fraud. Meanwhile, another story, this one from WBUR, offers tips for Medicare "wellness" visits.

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a new study in which linagliptin demonstrated statistically significant reductions in blood glucose levels (HbA1c) after 12 weeks (the study's primary endpoint) in adults with type 2 diabetes (T2D) with moderate to severe renal impairment, compared with placebo. Most patients had T2D for more than ten years (76 percent) and were on insulin (86 percent).

Alcohol intake linked to increased risk of hypertension in adults with Type 2 diabetes

Drinking eight or more alcoholic beverages a week may increase the risk of high blood pressure (also called hypertension) among adults with Type 2 diabetes, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

Study shows the feasibility of using gene therapy to treat chronic traumatic encephalopathy

A new study shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy.

Prehabilitation before knee replacement surgery may improve functional ability in osteoarthritis patients

An exercise program designed by researchers at the University of Louisville for patients with severe knee arthritis improves leg strength and patients' functional ability before knee replacement surgery, according to recent report in The Journal of Strength and Conditioning Research.

Read more Medical News

› Verified 6 days ago